Meet CombiGene at the Cell & Gene Meeting on the Med conference April 23-25, 2019 in Barcelona, Spain!
Meet CombiGene at the Cell & Gene Meeting on the Med conference April 23-25, 2019 in Barcelona, Spain! Europe’s premier annual conference in the cell and gene therapy sector. The meeting features expert-led panels, in-depth keynote speeches, and presentations by leading publicly traded and privately held companies from around the globe.
For more information on the meeting:
CombiGene’s vision is to provide patients affected by severe life-altering diseases with the prospect of a better life through novel gene therapies. CombiGene’s business concept is to develop effective gene therapies for severe life-altering diseases where adequate treatment is currently lacking. Development assets are sourced from an external research network and developed to achieve clinical proof of concept. Drug candidates for common diseases will be co-developed and commercialized through strategic partnerships, while the company may manage this process on its own for drugs targeting niched patient populations. The company is public and listed on the Swedish marketplace Nasdaq First North Growth Market and the company’s Certified Advisor is FNCA Sweden AB, +46 (0)852 80 03 99 firstname.lastname@example.org.